10-71677461-C-T
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4
The NM_022124.6(CDH23):c.1520C>T(p.Ser507Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000137 in 1,604,760 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. S507S) has been classified as Likely benign.
Frequency
Consequence
NM_022124.6 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive nonsyndromic hearing loss 12Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia
- nonsyndromic genetic hearing lossInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Usher syndrome type 1Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Usher syndrome type 1DInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CDH23 | NM_022124.6 | c.1520C>T | p.Ser507Leu | missense_variant | Exon 16 of 70 | ENST00000224721.12 | NP_071407.4 | |
| CDH23 | NM_001171930.2 | c.1520C>T | p.Ser507Leu | missense_variant | Exon 16 of 32 | NP_001165401.1 | ||
| CDH23 | NM_001171931.2 | c.1520C>T | p.Ser507Leu | missense_variant | Exon 16 of 26 | NP_001165402.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000985 AC: 15AN: 152226Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000134 AC: 32AN: 238658 AF XY: 0.000132 show subpopulations
GnomAD4 exome AF: 0.000141 AC: 205AN: 1452534Hom.: 1 Cov.: 31 AF XY: 0.000155 AC XY: 112AN XY: 720962 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152226Hom.: 0 Cov.: 32 AF XY: 0.0000941 AC XY: 7AN XY: 74360 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2
This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 507 of the CDH23 protein (p.Ser507Leu). This variant is present in population databases (rs201584731, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with CDH23-related conditions. ClinVar contains an entry for this variant (Variation ID: 45876). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CDH23 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Reported in the heterozygous state in a patient with hearing loss in published literature (PMID: 39161163); In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 39161163) -
not specified Uncertain:1
The Ser507Leu variant in CDH23 has not been reported in the literature nor previ ously identified by our laboratory. This residue is conserved across species and computational analyses (biochemical amino acid properties, homology, PolyPhen2, SIFT, AlignGVGD) suggest that the Ser507Leu variant may impact the protein. How ever, this information is not predictive enough to assume pathogenicity. In summ ary, the clinical significance of this variant cannot be determined with certain ty at this time. It should be noted that this lab has only sequenced a limited number of Turkish probands and no Turkish healthy controls. In addition, healthy control information is limited in either public databases or scientific literat ure, such that the full spectrum of benign variation has not yet been defined fo r this population. Future analysis could reveal that the Ser507Leu variant is co mmon in this population and therefore unlikely to be pathogenic. -
Inborn genetic diseases Uncertain:1
The c.1520C>T (p.S507L) alteration is located in exon 16 (coding exon 15) of the CDH23 gene. This alteration results from a C to T substitution at nucleotide position 1520, causing the serine (S) at amino acid position 507 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Usher syndrome type 1 Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at